Nutex Health Inc. (NUTX)
Nutex Health Statistics
Share Statistics
Nutex Health has 5.53M shares outstanding. The number of shares has increased by -89.06% in one year.
| Shares Outstanding | 5.53M |
| Shares Change (YoY) | -89.06% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.26% |
| Shares Floating | 3.53M |
| Failed to Deliver (FTD) Shares | 1.05K |
| FTD / Avg. Volume | 1.36% |
Short Selling Information
The latest short interest is 84.59K, so 1.56% of the outstanding shares have been sold short.
| Short Interest | 84.59K |
| Short % of Shares Out | 1.56% |
| Short % of Float | 2.4% |
| Short Ratio (days to cover) | 2.17 |
Valuation Ratios
The PE ratio is 3.1 and the forward PE ratio is 43.88. Nutex Health's PEG ratio is -0.02.
| PE Ratio | 3.1 |
| Forward PE | 43.88 |
| PS Ratio | 0.34 |
| Forward PS | 1.9 |
| PB Ratio | 0 |
| P/FCF Ratio | 0.01 |
| PEG Ratio | -0.02 |
Enterprise Valuation
Nutex Health has an Enterprise Value (EV) of 270.86B.
| EV / Sales | 564.35 |
| EV / EBITDA | 1822.08 |
| EV / EBIT | 11.7 |
| EV / FCF | 11.7 |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 1.56.
| Current Ratio | 2.08 |
| Quick Ratio | 2.06 |
| Debt / Equity | 1.56 |
| Debt / EBITDA | 2.11K |
| Debt / FCF | 13.57 |
| Interest Coverage | 6.55 |
Financial Efficiency
Return on Equity is 0.03% and Return on Invested Capital is 0.02%.
| Return on Equity | 0.03% |
| Return on Assets | 0.01% |
| Return on Invested Capital | 0.02% |
| Revenue Per Employee | $599.94K |
| Profits Per Employee | $65.22K |
| Employee Count | 800 |
| Asset Turnover | 0 |
| Inventory Turnover | 0.1 |
Taxes
| Income Tax | 14.48M |
| Effective Tax Rate | 13.19% |
Stock Price Statistics
The stock price has increased by 2026.8% in the last 52 weeks. The beta is 2.2, so Nutex Health's price volatility has been higher than the market average.
| Beta | 2.2 |
| 52-Week Price Change | 2026.8% |
| 50-Day Moving Average | 74.5 |
| 200-Day Moving Average | 37.89 |
| Relative Strength Index (RSI) | 75.48 |
| Average Volume (20 Days) | 77.14K |
Income Statement
In the last 12 months, Nutex Health had revenue of 479.95M and earned 52.18M in profits. Earnings per share was 10.23.
| Revenue | 479.95M |
| Gross Profit | 196.26M |
| Operating Income | 130.62M |
| Net Income | 52.18M |
| EBITDA | 148.65M |
| EBIT | 129.68M |
| Earnings Per Share (EPS) | 10.23 |
Balance Sheet
The company has 43.58B in cash and 314.28B in debt, giving a net cash position of -270.7B.
| Cash & Cash Equivalents | 43.58B |
| Total Debt | 314.28B |
| Net Cash | -270.7B |
| Retained Earnings | -356.89B |
| Total Assets | 655.32B |
| Working Capital | 151.61B |
Cash Flow
In the last 12 months, operating cash flow was 23.15B and capital expenditures -2.3M, giving a free cash flow of 23.15B.
| Operating Cash Flow | 23.15B |
| Capital Expenditures | -2.3M |
| Free Cash Flow | 23.15B |
| FCF Per Share | 4539.94 |
Margins
Gross margin is 40.89%, with operating and profit margins of 27.22% and 10.87%.
| Gross Margin | 40.89% |
| Operating Margin | 27.22% |
| Pretax Margin | 22.87% |
| Profit Margin | 10.87% |
| EBITDA Margin | 30.97% |
| EBIT Margin | 27.22% |
| FCF Margin | 4824.23% |
Dividends & Yields
NUTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 32.29% |
| FCF Yield | 14326.08% |
Analyst Forecast
The average price target for NUTX is $80, which is -42.4% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $80 |
| Price Target Difference | -42.4% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Jul 3, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 3, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -0.48 |
| Piotroski F-Score | 6 |